Alvine Pharmaceuticals Obtains $21,500,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=11c4a41f-5a6f-4641-8f8a-c4d8ab55bbe7&Preview=1
Date
9/15/2009
Company Name
Alvine Pharmaceuticals
Mailing Address
75 Shoreway Rd. San Carlos, CA 94070
Company Description
Alvine Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of Celiac sprue.
Website
http://www.alvinepharma.com
Transaction Type
Venture Equity
Transaction Amount
$21,500,000
Transaction Round
Series A
Proceeds Purposes
This funding will support the continued development of ALV003 as an innovative protease therapy for the treatment of celiac disease, and further our goal to be the leading company in this space.
M&A Terms
Venture Investor
Panorama Capital
Venture Investor
InterWest Partners
Venture Investor
Prospect Venture Partners
Venture Investor
Sofinnova Ventures
Venture Investor
Flagship Ventures